News - BioSpace
This year saw lofty highs and devastating lows for neuroscience drug developers like Bristol Myers Squibb, Eli Lilly and AbbVie, following the predictable pattern of successes and failures that characterizes this space.
BioSpace: Biotech, Pharmaceutical and Clinical Research News
Dec 11, 2010 · GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment model; Eli Lilly and Novo Nordisk pump new funds into manufacturing; and AbbVie makes a Cerevel comeback while uniQure clears a path toward …
About Us - BioSpace
BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
Join Our Team - BioSpace
BioSpace is the digital hub for life sciences news and jobs. Our mission is to provide essential insights, tools, and opportunities to connect the innovative organizations and talented professionals who advance health and quality of life across the globe.
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market
Nov 21, 2024 · Ahead of its investor event Thursday, Novartis revealed it is acquiring California-based biotech Kate Therapeutics, a move that “compliments” the pharma’s push to deliver innovative treatments for neuromuscular disorders and deepen its expertise in gene therapy. Novartis announced the deal in a press release for the investor event, though the company did …
Wet Lab vs Dry Lab: Challenges, Benefits and Skills Required
Jan 25, 2023 · Wet Lab. Most web labs require at least a degree in chemistry or biology.However, there are some entry-level roles that require only a high school diploma. Soft skills, such as proper handling techniques, are vital in order to work in a wet lab.
PTC Wins First FDA Nod for Direct-to-Brain Gene Therapy, Targets ...
Nov 14, 2024 · The FDA on Wednesday signed off on PTC Therapeutics’ gene therapy eladocagene exuparvovec-tneq for the treatment of aromatic L-amino acid decarboxylase deficiency. The treatment will be marketed under the brand name Kebilidi. With only around 350 cases reported in the literature, aromatic L-amino acid decarboxylase (AADC) deficiency is an …
Big Pharma’s Interest Grows in Evolving Cell and Gene ... - BioSpace
Oct 9, 2024 · In welcome remarks at the conference on Monday, Alliance for Regenerative Medicine (ARM) CEO Tim Hunt said there has been uptick in investment in cell and gene therapies in 2024, noting that 13 of the 15 largest pharma companies by market capitalization have an “active presence” in the sector.. Hunt said many leading Big Pharma …
Novartis, Ono Latest to Announce Billion-Dollar M&A Deals
Mar 5, 2024 · Pictured: A collage of biopharma M&A/ Nicole Bean for BioSpace. After a slow 2022 and early part of 2023, the pace of mergers and acquisitions in the pharmaceutical and biotech sectors has accelerated since the middle of last year, highlighted by Pfizer’s $43 billion takeover of Seagen.Since the calendar turned to 2024, we have seen some blockbusters, including …
Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 ...
Oct 29, 2024 · Third-quarter 2024 Cost of Sales (4) as a percentage of revenues decreased by 39.0 percentage points compared to the prior-year quarter, driven primarily by the non-recurrence of a non-cash charge of $5.6 billion recorded in the third quarter of 2023 for inventory write-offs and related charges ($4.7 billion for Paxlovid and $0.9 billion for Comirnaty (3)).